13 Publikationen
-
2024 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2993290Patient-reported outcomes in the subpopulation of patients with mismatch repair-deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG3031/RUBY trialPUB | DOI | WoS | PubMed | Europe PMC
Valabrega G, Powell MA, Hietanen S, Miller EM, Novak Z, Holloway R, Denschlag D, Myers T, Thijs AM, Pennington KP, Gilbert L, et al. (2024)
International Journal of Gynecological Cancer . -
2024 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2992805Impact of adjuvant therapy on oncologic outcomes in uterine-confined clear cell carcinoma of the endometriumPUB | DOI | WoS | PubMed | Europe PMC
Rios-Doria E, Nobre SP, Sassine D, Glaser G, Eriksson AG, Ataseven B, du Bois A, Makker V, Alektiar K, Leitao MMJ, Abu-Rustum NR, et al. (2024)
Gynecologic Oncology 190: 236-242. -
2024 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 29918862009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or both.PUB | DOI | WoS | PubMed | Europe PMC
Rios-Doria E, Abu-Rustum NR, Glaser G, McGree M, Eriksson AG, Pham M, Soliman P, Ataseven B, Alektiar K, Zamarin D, Leitao MLJ, et al. (2024)
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. -
2024 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2990941Stellungnahme der Kommission Uterus der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) zur neoadjuvanten Chemotherapie vor definitiver Radiochemotherapie bei Patientinnen mit lokal fortgeschrittenem ZervixkarzinomPUB | DOI | PubMed | Europe PMC
Tempfer C, Fehm T, Vordermark D, Marnitz-Schulze S, Beckmann MW, Denschlag D, Brucker S, Wallwiener M, Eichbaum M, Ataseven B, Hillemanns P (2024)
Geburtshilfe und Frauenheilkunde 84(6): 523-528. -
2024 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2987695Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapyPUB | DOI | WoS | PubMed | Europe PMC
Krug D, Vladimirova V, Untch M, Kühn T, Schneeweiss A, Denkert C, Ataseven B, Solbach C, Gerber B, Tesch H, Golatta M, et al. (2024)
Breast 74. -
2024 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987540Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancerPUB | WoS
Herold N, Schmolling J, Ernst C, Ataseven B, Bluemcke B, Schoemig-Markiefka B, Heikaus S, Goehring U-J, Engel C, Lampe B, Rhiem K, et al. (2024)
In: Abstracts from the 56th European Society of Human Genetics (ESHG) Conference. European Journal of Human Genetics , 32(Suppl. 1). London: Nature: 548. -
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2979534
Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma PatientsPUB | PDF | DOI | WoS | PubMed | Europe PMC
Imterat M, Harter P, Rhiem K, Heitz F, Schneider S, Concin N, Moubarak M, Welz J, Vrentas V, Traut A, Hahnen E, et al. (2023)
Cancers 15(9): 2534. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2985382PFS2 and adjustment of overall survival (OS) for subsequent anticancer therapy in patients (pts) with primary advanced or recurrent endometrial cancer (pA/rEC) treated with dostarlimab plus chemotherapy or chemotherapy alone in the ENGOT-EN3-NSGO/GOG-3031/RUBY trialPUB | DOI | WoS
Slomovitz BM, Raaschou-Jensen N, Coleman RL, Gilbert L, Powell MA, Cibula D, Ghamande S, Zavallone L, Mendivil AA, Ataseven B, Black D, et al. (2023)
In: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023. Annals of Oncology , 34(Suppl. 2). Amsterdam: Elsevier: S514-S515. -
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2984317Deep learning to predict breast cancer sentinel lymph node status on INSEMA histological imagesPUB | DOI | WoS | PubMed | Europe PMC
Marme F, Krieghoff-Henning E, Gerber B, Schmitt M, Zahm D-M, Bauerschlag D, Forstbauer H, Hildebrandt G, Ataseven B, Brodkorb T, Denkert C, et al. (2023)
European Journal of Cancer 195: 113390. -
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2984002Low anterior resection syndrome and its impact on quality of life of ovarian carcinoma patients: A prospective longitudinal studyPUB | DOI | WoS | PubMed | Europe PMC
Imterat M, Gebers G, Heitz F, Schneider S, Ehmann S, Welz J, du Bois A, Traut A, Walz MK, Concin N, Harter P, et al. (2023)
Gynecologic Oncology 178: 96-101. -
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2984318Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?PUB | DOI | WoS | PubMed | Europe PMC
Bizzarri N, Imterat M, Fruscio R, Giannarelli D, Perrone AM, Mancari R, Traut A, Rosati A, du Bois A, Ferrari D, De Iaco P, et al. (2023)
European Journal of Cancer 195: 113398. -
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2980959Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancerPUB | DOI | WoS | PubMed | Europe PMC
Herold N, Schmolling J, Ernst C, Ataseven B, Blümcke B, Schömig-Markiefka B, Heikaus S, Göhring U-J, Engel C, Lampe B, Rhiem K, et al. (2023)
Cancer Medicine . -
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2979540The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial designPUB | DOI | WoS | PubMed | Europe PMC
Inci MG, Sehouli J, Schnura E, Lee M, Roll S, Reinhold T, Klews J, Kaufner L, Niggemann P, Groeben H, Toelkes J, et al. (2023)
International Journal of Gynecological Cancer : ijgc-2023-004531.